043 - “Half Knowledge Can Hurt” with Shadeed Salam

Let's Combinate · 27 Jul 2022 · 1h 14m

What this episode covers

Shadeed Salem, Founder and President of Synergy Bioscience, explains the critical differences between validating test methods for pharmaceutical products versus medical devices. He details how drug methods focus on specificity, linearity, and detecting toxic degradation products (LOD/LOQ), while device methods prioritize physical, mechanical, and visual inspections using Gage R&R. Salem shares a war story about remediating 4,600 OOS investigations by separating R&D and QC labs and validating 136 unverified methods to close an FDA warning letter. He emphasizes that 'half knowledge can hurt' when engineers assume drug and device validation protocols are interchangeable without understanding the underlying regulatory and scientific distinctions.

Mentioned

Companies
Synergy Bioscience, Bristol Myers Squibb
Tools
HPLC, FTIR, Mass Spectrometry
Also
FDA, USP, ISO

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 40m

    How Jon Speer Met His Most Frequent Guest: Mike Drues

    Jon Speer, host of the Global Medical Device Podcast and founder of Greenlight Guru, revisits his 2014 origin story with Mike Drues, president of Vascular Sciences, to discuss their past debates on medical device design controls. They analyze the tension between following the literal letter of FDA regulations versus understanding their intent, arguing that many companies fail because they treat compliance as a checkbox exercise rather than a rigorous engineering process. The conversation highlights the danger of assuming users know their own needs, which stifles revolutionary product development in favor of evolutionary improvements, and emphasizes the critical importance of validating validation methods and addressing off-label use in risk management.

  • Global Medical Device Podcast · 38m

    #380: Navigating the Complex World of Combination Products with Subhi Saadeh

    Subhi Saadeh, host of the Combinate Podcast and expert in combination products, discusses the regulatory complexities of integrating drugs, devices, and biologics, including the differences between US FDA and EU regulatory pathways. He explains the definitions of single entity, co-packaged, and cross-labeled products, and addresses common misconceptions about the differences between drug and device quality systems. Saadeh also shares his journey of starting the podcast to maintain consistent learning and production, highlighting the importance of lifelong learning and leveraging coaching to balance technical and business aspects of the MedTech industry.

  • Global Medical Device Podcast · 36m

    Setting the Record Straight on Usability & Human Factors

    Mike Drues, a regulatory consultant for Vascular Sciences, joins host Jon Speer to clarify the distinction between usability and human factors in medical device development. They discuss how engineers often fail to test devices on actual end-users, leading to design flaws, and argue that FDA regulations are inconsistent, requiring extensive testing for simple devices while ignoring complex ones. The conversation emphasizes that usability testing should be risk-based, distinguishing between formative testing during development and summative testing after design freeze. Drues highlights the importance of realistic testing scenarios and warns against the 'tick-box' mentality that ignores off-label use risks.

  • Global Medical Device Podcast · 42m

    What are the Opportunities for Improvement (OFI) for Quality?

    Jon Speer, founder of Greenlight Guru, hosts Mike Drues of Vascular Sciences to discuss the definition and implementation of quality in the medical device industry. They argue that regulatory quality is about consistency rather than subjective 'good or bad' outcomes, and that quality management systems should serve as a business philosophy rather than just a compliance checklist. The conversation highlights the disconnect between product design validation and manufacturing process validation, especially in Class 1 and 2 devices.

  • Global Medical Device Podcast · 58m

    #392: Verification and Validation in MedTech: A Practical Guide with Devon Campbell

    Devon Campbell, a medical device consultant, explains the critical distinctions between verification (did we build the product right?) and validation (did we build the right product?) for early-stage medtech companies. He emphasizes that strong, testable user needs and design inputs are prerequisites for successful V&V, warning that weak requirements lead to validation failures. Campbell advocates for pre-verification testing to refine protocols and manage sample sizes, ensuring that design reviews and traceability are robust before formal regulatory submission.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.